Citigroup
NEPH icon

Citigroup’s Nephros NEPH Stock Holding History

Citigroup’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+1
New +$4 ﹤0.01% 5869

Other funds holding NEPH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Mesirow Financial Investment Management
Mesirow Financial Investment Management Chicago, Illinois $6.47B AUM 15.41% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Citigroup's NEPH Position: Q3 2026 in Review

Citigroup opened a new position in Nephros (NEPH) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #5869 among its holdings.

7 funds tracked by Wall St. Rank hold NEPH as of Q3 2026.

  • Citigroup held 1 share of Nephros worth $4 as of Q3 2026.
  • Nephros was a new Citigroup position in Q3 2026.
  • Nephros made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5869 holding.
  • 7 funds tracked by Wall St. Rank held Nephros as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.